COVID-19 and adherence to biologic therapies for psoriasis: An analysis of nationwide pharmacy claims data

BACKGROUND: Early after the onset of the COVID-19 pandemic, concerns were raised that the use of psoriasis treatments, particularly biologic therapies because of their immunosuppressant effects, could be associated with a poor prognosis in the case of COVID-19 infection. OBJECTIVE: To examine change...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Meiqi, Ferris, Laura K, Gabriel, Nico, Tadrous, Mina, Hernandez, Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284347/
https://www.ncbi.nlm.nih.gov/pubmed/36282925
http://dx.doi.org/10.18553/jmcp.2022.28.11.1213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284347/
https://www.ncbi.nlm.nih.gov/pubmed/36282925
http://dx.doi.org/10.18553/jmcp.2022.28.11.1213

Ejemplares similares